Stock Ticker

  • Loading stock data...

About Our Company

Who We Are

NaturalShrimp, Inc. (OTCQB: SHMP) a publicly traded agro-tech company, has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals.

NSI will develop fully contained and independent production facilities to raise Pacific white shrimp in an ecologically controlled, high-density, low cost environment in geographically strategic, high-density, metropolitan areas. NSI uses Vibrio Suppression Technology, a solution against infectious agents that helps to exclude and suppress harmful organisms, significantly better than competing BioFloc technology. The Company’s expansion plans include both domestic and international production facilities and distribution channels.

Company Timeline

Our History

2001

Proof of Concept – Raised shrimp indoors in a 200-gallon recirculating system using algae and artemia as feed for the shrimp.

2002/2003/2004

Prototype - Moved to a warehouse in San Antonio to construct, test, and evaluate raising shrimp in a larger system. Received U.S. patent using algae and artemia as feed for the shrimp.

2005/2006/2007

Pilot Plant – Warehouse testing was successful but determined that the system required too much algae and artemia to be commercially cost effective. Acquired 37 acres in La Coste, TX and constructed a greenhouse and a 30,000 square foot metal building with lined tanks and filtration equipment to evaluate using dry shrimp feed instead of algae and artemia on a commercial scale.

2008/2009/2010/2011

Filtration method research – Spent these years trying the traditional methods of filtration including biofloc and bioreactors. Began construction of 70,000 square foot joint venture biofloc building in Spain. Raised and sold tens of thousands of pounds of shrimp but could not achieve consistent production in high densities.

2012/2013/2014

Research – Evaluated the use of electrocoagulation technology to assist filtration for aquaculture. It demonstrated the ability to control both ammonia and bacteria which resulted in much better growth and survival but the equipment needed refinement.

2015/2016/2017

Development – Evaluated a clearwater system using refined electrocoagulation equipment that once again proved successful in maintaining water quality and great shrimp survival but the equipment required further refinements.

2018

Electrocoagulation Production – Using an improved electrocoagulation system proved successful again throughout the shrimp grow out period. Received U.S patent for using electrocoagulation for shrimp extended to include other aquatic species.

2019

Pilot Plant Renovation – Replaced lined tanks with fiberglass tanks and acquired additional electrocoagulation systems.

2020

Regular Production – Begin weekly production from a renovated pilot plant and construct an additional larger production facility in La Coste, TX.

2021

Expansion – Establish multiple production facilities in the United States.